Multidisciplinary Treatment Of The Patient With A Severe Irritable Bowel Syndrome

The patient E., aged 39, was described with a severe form of the irritable bowel syndrome that developed after the stress. In addition to the clinical manifestations of IBS, the patient got the somatoform disorders, which manifested itself with a large number of extraintestinal symptoms and led to a disability. According to the recommendations of the Rome Criteria IV 2016, the main medicines for the treatment of biopsychosocial model of IBS are antidepressants. The remission of the disease with a complete recovery of the patient's disability was achieved by duloxetine, an antidepressant from the group of serotonin and noradrenaline reuptake inhibitors.